Improving the Early Detection of Cardiometabolic Disease Risk

Sponsor
University of Southern Mississippi (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05885672
Collaborator
University of Mississippi Medical Center (Other)
200
1
12
16.7

Study Details

Study Description

Brief Summary

The goal of this observational study is to reduce an individual's cardiometabolic disease risk by improving the ability to detect cardiometabolic disease risk in young adults through the use of novel technologies that increase access to and examine the utility of, a continuous metabolic syndrome severity score. An additional goal of this study is to understand the barriers to engagement in health-promoting behaviors and beliefs about interventions aimed at mitigating metabolic syndrome risk through a brief online lifestyle intervention.

The main question[s] it aims to answer are:
  • Can a smartphone-based imaging system accurately predict a continuous metabolic syndrome severity score, in addition to other markers of cardiometabolic disease, in young adults?

  • What is the relationship between autonomic dysfunction and metabolic syndrome severity in a cohort of young adults?

  • What is the relationship between peripheral vascular dysfunction and metabolic syndrome severity in a cohort of young adults?

  • What are the associations between metabolic syndrome severity and gait and functional ability in young adults using novel markerless motion capture technology?

  • What are the attitudes and barriers towards lifestyle interventions targeted to reduce metabolic syndrome severity?

  • What are the treatment-seeking and willingness to engage behaviors toward a webpage focused on lifestyle interventions to reduce metabolic syndrome severity?

Participants will be asked to undergo several assessments across four separate days which are design designed to determine the associations between cardiometabolic health markers and components of:

  • body composition

  • cardiovascular function

  • functional ability

  • attitudes and behaviors towards health-related interventions

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Online psychoeducational lifestyle intervention

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Multi-Modal Approach to Improving the Early Detection of Cardiometabolic Disease Risk
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Jul 31, 2024
Anticipated Study Completion Date :
Jul 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Young Adults

Adults between the ages of 18 and 39 years

Behavioral: Online psychoeducational lifestyle intervention
A webpage-baed intervention focused on lifestyle interventions that aim to reduce metabolic syndrome severity.

Outcome Measures

Primary Outcome Measures

  1. Blood Pressure [Baseline]

    Resting systolic and diastolic blood pressure

  2. Waist Circumference [Baseline]

    Circumference of the waist measured by tape measure at the level of the iliac crest

  3. Fasting blood glucose [Baseline]

    Blood glucose collected from capillary blood

  4. Blood lipids [Baseline]

    Triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol collected from capillary blood

  5. Metabolic syndrome severity score [Baseline]

    A race and sex-specific equation that uses systolic blood pressure, waist circumference, and blood lipids to calculate a single continuous score that quantifies a person's overall cardiometabolic disease severity on a continuum where higher scores equal a worse outcome and negative scores equal a better outcome. The scale does not have bound and is infinite in positive and negative directions.

  6. Insulin [Baseline]

    Insulin collected from intravenous blood

  7. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) [Baseline]

    Equation that estimates insulin resistance from glucose and insulin measurements

  8. Tumor necrosis factor-alpha [Baseline]

    Common biomarker of systemic inflammation collected from intravenous blood

  9. Body fat percentage [Baseline]

    The percentage of body fat estimated using smartphone-based digital imaging

  10. Fat mass [Baseline]

    The weight of fat mass in kilograms estimated using smartphone-based digital imaging

  11. Fat-free mass [Baseline]

    The weight of fat-free mass in kilograms estimated using smartphone-based digital imaging

  12. Body circumferences [Baseline]

    Central (trunk) and segmental (arms and legs) circumference estimated using smartphone-based digital imaging

  13. Heart Rate Variability [Baseline]

    Index of cardiac autonomic control collected via one-lead electrocardiogram

  14. Cardiac Baroreflex Sensitivity [Baseline]

    Measure of parasympathetic and sympathetic regulation collected via one-lead electrocardiogram and finger photoplethysmography

  15. Flow-mediated changes in vascular diameter [Baseline]

    Changes in vascular diameter during 5 minutes of post-occlusive reactive hyperemia collected via duplex Doppler ultrasound

  16. Flow-mediated changes in blood flow [Baseline]

    Changes in blood flow during 5 minutes of post-occlusive reactive hyperemia collected via duplex Doppler ultrasound

  17. Flow-mediated changes in blood pressure [Baseline]

    Changes in blood pressure during 5 minutes of post-occlusive reactive hyperemia collected via finger photoplethysmography

  18. Flow-mediated changes in vascular conductance [Baseline]

    Changes in vascular conductance during 5 minutes of post-occlusive reactive hyperemia calculated as flow per unit of blood pressure

  19. Flow-mediated changes in vascular resistance [Baseline]

    Changes in vascular resistance during 5 minutes of post-occlusive reactive hyperemia calculated as blood pressure per unit of flow

  20. Flow-mediated changes in skeletal muscle oxygenation [Baseline]

    Changes in skeletal muscle oxygenated/deoxygenated hemoglobin saturation during 5 minutes of post-occlusive reactive hyperemia collected via near-infrared spectroscopy

  21. Passive Limb Movement Mediated Changes in Vascular Diameter [Baseline]

    Changes in vascular diameter during passive limb movement collected via duplex Doppler ultrasound

  22. Passive Limb Movement Mediated Changes in Blood Flow [Baseline]

    Changes in blood flow during passive limb movement collected via duplex Doppler ultrasound

  23. Passive Limb Movement Mediated Changes in Blood Pressure [Baseline]

    Changes in blood pressure during passive limb movement collected via finger photoplethysmography

  24. Passive Limb Movement Mediated Changes in Vascular Conductance [Baseline]

    Changes in vascular conductance during passive limb movement calculated as flow per unit of pressure

  25. Passive Limb Movement Mediated Changes in Vascular Resistance [Baseline]

    Changes in vascular resistance during passive limb movement calculated as the pressure per unit of flow

  26. Passive Limb Movement Mediated Changes in Skeletal Muscle Oxygenation [Baseline]

    Changes in skeletal muscle oxygenation during passive limb movement collected via near-infrared spectroscopy

  27. Carotid-Femoral Pulse Wave Velocity [Baseline]

    Index of arterial stiffness collected during rest collected via applanation tonometry and auscultation based wave analysis

  28. Cold Pressor Test Blood Pressure Responses [Baseline]

    Changes in blood pressure during three minutes of cold-pressor activation collected via finger photoplethysmography

  29. Cold Pressor Test Heart Rate Responses [Baseline]

    Changes in heart rate during three minutes of cold-pressor activation collected via one-lead electrocardiogram

  30. Cold Pressor Test Vascular Conductance Responses [Baseline]

    Changes in vascular conductance during three minutes of cold-pressor activation calculated as flow per unit of pressure

  31. Cold Pressor Test Vascular Resistance Responses [Baseline]

    Changes in vascular resistance during three minutes of cold-pressor activation calculated as pressure per unit of flow

  32. Cold Pressor Test stroke volume Responses [Baseline]

    Changes in stroke volume during three minutes of cold-pressor activation collected via finger photoplethysmography or duplex Doppler ultrasound

  33. Cold Pressor Test Cardiac Output Responses [Baseline]

    Changes in cardiac output during three minutes of cold-pressor activation collected via finger photoplethysmography or duplex Doppler ultrasound

  34. Metaboreflex Blood Pressure Responses [Baseline]

    Changes in blood pressure during rhythmic handgrip exercise with graded blood flow restriction (minutes 0, 2, 4, 6, and 8) collected via finger photoplethysmography

  35. Metaboreflex Heart Rate Responses [Baseline]

    Changes in heart rate during rhythmic handgrip exercise with graded blood flow restriction (minutes 0, 2, 4, 6, and 8) collected via one-lead electrocardiogram

  36. Metaboreflex Vascular Conductance Responses [Baseline]

    Changes in vascular conductance during rhythmic handgrip exercise with graded blood flow restriction (minutes 0, 2, 4, 6, and 8) calculated as flow per unit of pressure

  37. Metaboreflex Vascular Resistance Responses [Baseline]

    Changes in vascular resistance during rhythmic handgrip exercise with graded blood flow restriction (minutes 0, 2, 4, 6, and 8) calculated as pressure per unit of flow

  38. Metaboreflex Stroke Volume Responses [Baseline]

    Changes in stroke volume during rhythmic handgrip exercise with graded blood flow restriction (minutes 0, 2, 4, 6, and 8) collected via finger photoplethysmography or duplex Doppler ultrasound

  39. Metaboreflex Cardiac Output Responses [Baseline]

    Changes in cardiac output during rhythmic handgrip exercise with graded blood flow restriction (minutes 0, 2, 4, 6, and 8) collected via finger photoplethysmography or duplex Doppler ultrasound

  40. Functional Sympatholysis Blood Flow Responses [Baseline]

    Changes in limb blood flow during three minutes of cold-pressor activation with superimposed rhythmic handgrip exercise Collected via finger photoplethysmography

  41. Functional Sympatholysis Vascular Conductance Responses [Baseline]

    Changes in vascular conductance during three minutes of cold-pressor activation with superimposed rhythmic handgrip exercise calculated as flow per unit of pressure

  42. Functional Sympatholysis Vascular Resistance Responses [Baseline]

    Changes in vascular resistance during three minutes of cold-pressor activation with superimposed rhythmic handgrip exercise Calculated as pressure per unit of flow

  43. Functional Sympatholysis Blood Pressure Responses [Baseline]

    Changes in blood pressure during three minutes of cold-pressor activation with superimposed rhythmic handgrip exercise collected via finger photoplethysmography

  44. Gait velocity [Baseline]

    Self-selected walking velocity over level ground measured with a timing gate system.

  45. Gait velocity [Immediately post 6-minute walk test]

    Self-selected walking velocity over level ground measured with a timing gate system.

  46. Stride Length [Baseline]

    Length of stride, measured as the lateral distance between feet during walking measured with a motion capture system.

  47. Stride Length [Immediately post 6-minute walk test]

    Length of stride, measured as the lateral distance between feet during walking measured with a motion capture system.

  48. Stride Width [Baseline]

    Width of stride, measured as the lateral distance between feet during walking measured with a motion capture system.

  49. Stride Width [Immediately post 6-minute walk test]

    Width of stride, measured as the lateral distance between feet during walking measured with a motion capture system.

  50. Gait Cadence [Baseline]

    Steps taken per minute measured with a motion capture system.

  51. Gait Cadence [Immediately post 6-minute walk test]

    Steps taken per minute measured with a motion capture system.

  52. Ankle joint angle [Baseline]

    Ankle angle during level ground walking measured in degrees measured with a motion capture system.

  53. Ankle joint moment [Baseline]

    Ankle moment during level ground walking measured in newton-meters measured with a motion capture system.

  54. Ankle joint angle [Immediately post 6-minute walk test]

    Ankle angle during level ground walking measured in degrees measured with a motion capture system.

  55. Ankle joint moment [Immediately post 6-minute walk test]

    Ankle moment during level ground walking measured in newton-meters measured with a motion capture system.

  56. Knee joint angle [Baseline]

    Knee angle during level ground walking measured in degrees measured with a motion capture system.

  57. Knee joint moment [Baseline]

    Knee moment during level ground walking measured in newton-meters measured with a motion capture system.

  58. Knee joint angle [Immediately post 6-minute walk test]

    Knee angle during level ground walking measured in degrees measured with a motion capture system.

  59. Knee joint moment [Immediately post 6-minute walk test]

    Knee moment during level ground walking measured in newton-meters measured with a motion capture system.

  60. Hip joint angle [Baseline]

    Hip angle during level ground walking measured in degrees measured with a motion capture system.

  61. Hip joint moment [Baseline]

    Hip moment during level ground walking measured in newton-meters measured with a motion capture system.

  62. Hip joint angle [Immediately post 6-minute walk test]

    Hip angle during level ground walking measured in degrees measured with a motion capture system.

  63. Hip joint moment [Immediately post 6-minute walk test]

    Hip moment during level ground walking measured in newton-meters measured with a motion capture system.

  64. Ground reaction forces [Baseline]

    Three-dimensional ground reaction forces during level ground walking measured with a motion capture system.

  65. Ground reaction forces [Immediately post 6-minute walk test]

    Three-dimensional ground reaction forces during level ground walking measured with a motion capture system.

  66. Center of pressure - right leg [Baseline]

    Whole body center of pressure displacement

  67. Center of pressure - left leg [Baseline]

    Whole body center of pressure displacement

  68. Center of pressure - bilateral [Baseline]

    Whole body center of pressure displacement

  69. Timed-up and go [Baseline]

    Time (seconds) for participant to stand up from chair, walk 3 meters, and return

  70. Sit-to-stand [Baseline]

    Time (seconds) for participant to stand up from chair and sit back down (5 repetitions)

  71. Time Up and Down Stairs [Baseline]

    Time (seconds) for participant to stand ascend and descend a single flight (10 steps) of stairs

  72. Isometric strength [Baseline]

    Isometric muscle strength of hip flexors and extensors, knee flexors and extensors, and ankle dorsi- and plantar flexors of the right leg

  73. Visceral adipose tissue [Baseline]

    Absolute fat-mass around the visceral organs in kilograms measured using dual-energy x-ray absorptiometry.

  74. Subcutaneous adipose tissue [Baseline]

    Absolute fat-mass under the cutaneous layer of the skin in kilograms measured using dual-energy x-ray absorptiometry

  75. Motivation and Attitudes Towards Health [Baseline]

    Motivation and Attitudes Towards Changing Health Scale. Scores range from 5-45, which higher scores indicating higher motivation and more positive attitudes towards changing health behavior

  76. Readiness for Behavior Change [Baseline]

    Readiness for Change Questionnaire. Separate subscales are calculated for each of the 5 stages of change (pre-contemplation, contemplation, preparation, action, maintenance) with higher scores indicating a greater likelihood of an individual being in that stage of change versus another. The 12 items on this scale are scored on a scale of -2 to +2 (-2 = Strongly disagree, -1 Disagree, 0 = Unsure, +1 = Agree, +2 = Strongly Agree).

  77. Treatment Seeking Behavior [Baseline]

    Whether participant engages with educational webpage about health behavior change. This is a dichotomous yes/no value based on whether someone clicks on the webpage or not.

Secondary Outcome Measures

  1. Height [Baseline]

    Height collected using a stadiometer

  2. Weight [Baseline]

    Weight collected using a stadiometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 39 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • adults between the ages of 18-39 years of age
Exclusion Criteria:
  • Younger than 18 or older than 39

  • Pregnant

  • Breastfeeding or lactating

  • Missing any limbs or part of a limb

  • Having a substantial amount of metal implants (metal plates or complete joint replacements)

  • Having a pacemaker or any other electrical implant

  • Type I diabetes

  • Gestational diabetes

  • Taking insulin

  • Diagnosed heart failure, cardiomyopathy (dilated or hypertrophic), valvular disease

  • Any history of severe traumatic brain injury or mild traumatic brain injury within the last two years

  • Kidney disease

  • Liver disease

  • Thyroid disease

  • Any diagnosed neurological or neurodegenerative diseases

  • Having received ionizing radiation from a medical procedure within the last 30 days

  • Being on a medically prescribed diet

  • Having donated blood or plasma in the last 20 days prior to blood collection procedures

  • Taking any supplements/medications that may interfere with the results of the study

  • Any injury or physical impairment that would prevent performing any functional measures for this study

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Southern Mississippi - School of Kinesiology and Nutrition Hattiesburg Mississippi United States 39406

Sponsors and Collaborators

  • University of Southern Mississippi
  • University of Mississippi Medical Center

Investigators

  • Principal Investigator: Austin J Graybeal, PhD, University of Southern Mississippi
  • Principal Investigator: Jon Stavres, PhD, University of Southern Mississippi
  • Principal Investigator: Tanner Thorsen, PhD, University of Southern Mississippi
  • Principal Investigator: Megan Renna, PhD, University of Southern Mississippi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Southern Mississippi
ClinicalTrials.gov Identifier:
NCT05885672
Other Study ID Numbers:
  • 23-0446
First Posted:
Jun 2, 2023
Last Update Posted:
Jun 2, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 2, 2023